Multicentric reticulohistiocytosis with extra-mammillary Paget’s disease: a case report
© Huang et al.; licensee BioMed Central Ltd. 2013
Received: 15 March 2013
Accepted: 14 October 2013
Published: 29 October 2013
Multicentric reticulohistiocytosis (MRH) is a very rare systemic disease with variable phenotypic presentation and a high rate of misdiagnosis. Here we describe a patient with MRH and extra-mammillary Paget’s disease (EMPD), a diagnosis that has not previously been described in the literature.
KeywordsMulticentric reticulohistiocytosis (MRH) Extra-mammillary Paget’s disease (EMPD) First report
Multicentric reticulohistiocytosis (MRH) is a very rare disease and was first identified in 1936 [1–6]. The disease can involve the skin, mucosa, joints and/or muscles. Owing to the frequency of accompanying joint symptoms, MRH is easily misdiagnosed as rheumatoid arthritis or dermatomyositis. Patients can also present with co-morbid tumors. Here, we describe a case with co-morbidity of MRH and extra-mammillary Paget’s disease (EMPD).
On 10 May 2012, a 47-year-old woman was admitted to our department because of a 1-year history of polyarthralgia and multiple papules that had first appeared 2 months prior. Five years previously, the patient had noticed an edematous rash on her left vulva; the rash was accompanied by a persistent itch. Scratching the rash resulted in the release of clear fluid. She went to local hospitals several times and was diagnosed with eczema. One year prior to presentation at our clinic, the patient began to experience symmetrical polyarthralgia, which was typically mild but exacerbated with exercise. The patient’s pain radiated from her ankle to her knee, and also from her finger to her palm, wrist, elbow, shoulder and spine, in series. The patient eventually experienced difficulty with flexion of both upper and lower limbs, such that walking became difficult. Two months later, she noticed that multiple red papules had appeared on her neck, upper chest and the distal portion of her dorsal finger. At each of several local hospitals, the patient was diagnosed with rheumatoid arthritis and prescribed oral medication such as ibuprofen tablets; none of these had any effect. Six months ago, the patient lost 3 kg from her baseline weight. She was married with a son and a daughter, both of whom were healthy. Her father and younger brother had died of liver cancer. Notably, the patient had been menopausal for 3 years. Her medical history and personal history were normal.
The clinical manifestation, auxiliary examinations and pathological examination suggested a diagnosis of concomitant MRH and EMPD. A regimen of tripterygium glycosides (a traditional Chinese medicine, which is immunosuppressant, 30 mg/pc) 6 pcs/d was recommended, to avoid any adverse effects. Routine blood examination was performed to monitor the patient’s hepatic and renal function. The patient was also treated with prednisone 5 mg/pc (every week for 1 month, and then once a month), acetate tablets (20 mg/d) and surgical intervention when necessary.
Two weeks later, the patient reported that her arthralgia had improved noticeably, which led to a reduction in the number of papules as well as an improved quality of life. The patient was transferred to the gynecology department and the genital tumor was extensively resected. No infiltration of nearby tissues and organs was found. Colonoscopy and colposcopy results were unremarkable. A telephone follow-up at 1 month revealed that the patient’s MRH was under control, and the patient was engaged in ongoing treatment for her EMPD.
The pathogenesis underlying MRH remains to be determined. The condition is more than twice as common in women as men, and typically affects middle-aged adults . This condition is often co-morbid with tumors, diabetes mellitus, hyperlipidemia and hypothyroidism [7, 8]. In the patient presented here, the clinical manifestations included a rash and painless papulonodules. In MRH patients, 60% report concomitant arthritis of the peripheral joints and 50% report issues related to mucus membranes or muscles . A definitive diagnosis requires a skin biopsy [10, 11]. There is no specific treatment for this disease, but inflammation is kept under control through the use of glucocorticoids, immunosuppressants, biological agents, TNF-α, IL-1β, tripterygium glycosides and NSAIDs.
EMPD is considered to be an eczematoid carcinoma of the breast, which is an adenocarcinoma that is rarely observed on the skin. EMPD typically affects the vulva. Patients are advised to undergo surgery owing to the risk of relapse.
This patient presented symptoms of vulvar malignancy prior to MRH. Her MRH was originally misdiagnosed as rheumatoid arthritis and her EMPD of the vulva was initially misdiagnosed as eczema. Treatments based on these diagnoses were futile.
We have not been able to find any obvious similarities in the pathophysiology of MRH and EMPD. Some think that MRH is a real paraneoplastic syndrome  and related to malignancy. However, the underlying relation is still not determined  even though there have been several reports of the co-morbidity of MRH and urologic neoplasms. Further studies are needed to investigate the relation between MRH and EMPD for this case.
MRH is a rare disease that is very similar to rheumatoid arthritis and diabetes mellitus, which often leads to misdiagnosis. Co-morbidity with EMPD can make an accurate diagnosis even more challenging [2–6]. This case report should aid medical practitioners if they encounter similar clinical presentations.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Extra-mammillary Paget’s disease
Non-steroidal anti-inflammatory drugs
Tumor necrosis factor.
This study was supported by a research fund from the Zhejiang Provincial Administration of Traditional Chinese Medicine (2012ZB093).
- Liang GC, Granston AS: Complete remission of multicentric reticulohistiocytosis with combination therapy of steroid, cyclophosphamide, and low-dose pulse methotrexate. Case report, review of the literature, and proposal for treatment. Arthritis Rheum 1996, 39: 171–174. 10.1002/art.1780390125View ArticlePubMedGoogle Scholar
- Zelger B, Cerio R, Soyer HP, Misch K, Orchard G, Wilson-Jones E: Reticulohistiocytoma and multicentric reticulohistiocytosis. Histopathologic and immunophenotypic distinct entities. Am J Dermatopathol 1994, 16: 577–584. 10.1097/00000372-199412000-00001View ArticlePubMedGoogle Scholar
- Campbell DA, Edwards NL: Multicentric reticulohistiocytosis: systemic macrophage disorder. Baillieres Clin Rheumatol 1991, 5: 301–319. 10.1016/S0950-3579(05)80285-7View ArticlePubMedGoogle Scholar
- Gorman JD, Danning C, Schumacher HR, Klippel JH, Davis JC Jr: Multicentric reticulohistiocytosis: case report with immunohistochemical analysis and literature review. Arthritis Rheum 2000, 43: 930–938. 10.1002/1529-0131(200004)43:4<930::AID-ANR27>3.0.CO;2-AView ArticlePubMedGoogle Scholar
- Lesniak MS, Viglione MP, Weingart J: Multicentric parenchymal xanthogranuloma in a child: case report and review of the literature. Neurosurgery 2002, 51: 1493–1498. discussion 1498PubMedGoogle Scholar
- Munoz-Santos C, Sabat M, Saez A, Gratacos J, Luelmo J: Multicentric reticulohistiocytosis-mimicking dermatomyositis. Case report and review of the literature. Dermatology 2007, 214: 268–271. 10.1159/000099594View ArticlePubMedGoogle Scholar
- Berti E, Zelger B, Caputo R: Reticulohistiocytosis. In World Health Organization Classification of Tumours: Pathology and Genetics of Skin Tumours. Edited by: LeBoit P, Burg G, Weedon D. Lyon: LARC Press; 2006:224–225.Google Scholar
- Liu YH, Fang K: Multicentric reticulohistiocytosis with generalized systemic involvement. Clin Exp Dermatol 2004, 29: 373–376. 10.1111/j.1365-2230.2004.01531.xView ArticlePubMedGoogle Scholar
- Rapini RP: Multicentric reticulohistiocytosis. Clin Dermatol 1993, 11: 107–111. 10.1016/0738-081X(93)90105-LView ArticlePubMedGoogle Scholar
- Miettinen M, Fetsch JF: Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol 2006, 30: 521–528. 10.1097/00000478-200604000-00014View ArticlePubMedGoogle Scholar
- Kocanaogullari H, Ozsan H, Oksel F, Ozturk G, Kandiloglu G, Ustun EE, Doganavsargil E: Multicentric reticulohistiocytosis. Clin Rheumatol 1996, 15: 62–66. 10.1007/BF02231688View ArticlePubMedGoogle Scholar
- Nicol C, Quereux G, Renaut JJ: Paraneoplastic multicentric reticulohistiocytosis. Ann Dermatol Venereol 2011, 138(5):405–408. 10.1016/j.annder.2011.01.030View ArticlePubMedGoogle Scholar
- Tan BH, Barry CI, Wick MR: Multicentric reticulohistiocytosis and urologic carcinomas: a possible paraneoplastic association. J Cutan Pathol 2011, 38(1):43–48. 10.1111/j.1600-0560.2010.01608.xView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.